Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 30, 2015 6:46 AM ET

Pharmaceuticals

Company Overview of Shire Human Genetic Therapies, Inc.

Company Overview

Shire Human Genetic Therapies, Inc., a biopharmaceutical company, develops, and commercializes therapeutics for the treatment of genetic diseases caused by protein deficiencies. The company markets and sells Replagal, an enzyme replacement therapy for the long-term treatment of patients with Fabry disease, in 34 countries outside the United States. The company’s primary clinical programs include iduronate-2-sulfatase, an enzyme replacement therapy for the treatment of hunter syndrome, which is in phase III clinical trials; and Gene-Activated glucocerebrosidase, an enzyme replacement therapy for the treatment of Gaucher disease, which is in phase I/ II clinical trials. In addition, the compan...

700 Main Street

Cambridge, MA 02139

United States

Founded in 1988

400 Employees

Key Executives for Shire Human Genetic Therapies, Inc.

Head of Research and Development
Age: 55
Senior Vice President and Franchise Lead of Mucopolysaccharides
Age: 50
Vice President of Process Development
Corporate Communications Manager
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
EMD Pharmaceuticals, Inc. United States
Golden State Medical Supply, Inc. United States
Keel Pharmaceuticals, Inc. United States
AlamX LLC United States
Accord Healthcare, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Shire Human Genetic Therapies, Inc., please visit www.shire.com/shireplc/financialreports/ar2005/pages/review/hgt.html. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.